NCT00446147
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +6 more
- Locations
-
Not specified
Clinical trial condition
Drug Hypersensitivity
Explore clinical trials studying Drug Hypersensitivity. Study availability and eligibility vary by location and protocol.
59 public trials
6 recruiting studies
Drug Hypersensitivity trial results
NCT01316406
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +6 more
- Locations
-
- Imelda Bonheiden, Belgium
- Institute Jules Bordet Brussels, Belgium
- AZ Maria Middelares St-Niklaas, Belgium
- Iniversitätsklinikum Hamburg Eppendorf Hamburg, Germany
NCT01219023
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Completed
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
NCT01488396
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +17 more
- Locations
-
- Mahidol university Bangkok, Thailand
NCT00248248
- Conditions
- Adnexal Diseases, Chemically-Induced Disorders, Dermatitis, +21 more
- Locations
-
- Southeastern Gynecologic Oncology Atlanta, Georgia, United States
Completed
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
NCT00346450
- Conditions
- Chemical Injury, Chemically-Induced Disorders, Conjunctival Diseases, +20 more
- Locations
-
- Singapore National Eye Centre Singapore
Completed
Stevens-Johnson Syndrome Antimicrobial
NCT00844038
- Conditions
- Autoimmune Diseases, Chemically-Induced Disorders, Dermatitis, +15 more
- Locations
-
- University of Pernambuco Recife, Pernambuco, Brazil
Active, Not Recruiting
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
NCT05165069
- Conditions
- Breast Diseases, Breast Neoplasms, Chemically-Induced Disorders, +10 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
Active, Not Recruiting
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
NCT05575037
- Conditions
- Aspirin-Sensitive Asthma With Nasal Polyps, Aspirin-exacerbated Respiratory Disease, Asthma, +16 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States